| Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma (NCT00735345) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2008-08-01 |
| Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer (NCT00722605) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
| Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer (NCT00702884) | Tony Bekaii-Saab | 2008-06-30 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer (NCT00655876) | Radiation Therapy Oncology Group | 2008-06-01 |
| Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers (NCT00848783) | NYU Langone Health | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer (NCT00681421) | Tokyo University | 2008-05-01 |
| Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer (NCT00686114) | Wenzhou Medical University | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer (NCT00681330) | Tokyo University | 2008-05-01 |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer (NCT00978549) | Cambridge University Hospitals NHS Foundation Trust | 2008-04-01 |
| Evaluation of Polyflex Stenting in Esophageal Cancer Patients (NCT00727376) | University of Louisville | 2008-03-01 |
| S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery (NCT00659113) | Yonsei University | 2008-03-01 |
| Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer (NCT00971841) | Bristol-Myers Squibb | 2008-03-01 |
| Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer (NCT00509561) | Wales Cancer Trials Unit | 2008-02-01 |
| Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer (NCT00701857) | University of Arizona | 2008-02-01 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer (NCT00632333) | Teikyo University | 2008-02-01 |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach (NCT00601705) | Case Comprehensive Cancer Center | 2008-01-05 |
| Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes (NCT01033695) | Odense University Hospital | 2008-01-01 |
| Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer (NCT00573131) | Boston Scientific Corporation | 2008-01-01 |
| Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma (NCT02133612) | Chinese Academy of Medical Sciences | 2007-12-01 |
| Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer (NCT01034332) | National Taiwan University Hospital | 2007-12-01 |
| Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal Cancer (NCT01640860) | Chonnam National University Hospital | 2007-12-01 |
| Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery (NCT00539617) | University of California, San Francisco | 2007-10-05 |
| Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic (NCT00533884) | Vanderbilt University Medical Center | 2007-10-01 |
| Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer (NCT00911092) | Centre Oscar Lambret | 2007-10-01 |
| Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial? (NCT00583934) | University of California, Davis | 2007-09-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| 4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic Malignancies (NCT00531180) | M.D. Anderson Cancer Center | 2007-08-21 |
| Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001) (NCT00522795) | Brown University | 2007-08-01 |
| Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) (NCT00915850) | Wakayama Medical University | 2007-08-01 |
| Erlotinib in Treating Patients With Barrett Esophagus (NCT00566800) | Kansas City Veteran Affairs Medical Center | 2007-07-01 |
| Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery (NCT00544362) | Federation Francophone de Cancerologie Digestive | 2007-07-01 |
| p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer (NCT00525200) | Daniela Kandioler | 2007-06-01 |
| Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Surgery (NCT00898495) | ECOG-ACRIN Cancer Research Group | 2007-05-11 |
| Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract (NCT00511264) | Odense University Hospital | 2007-05-01 |
| A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen (NCT00623831) | Ludwig Institute for Cancer Research | 2007-05-01 |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer (NCT00524186) | Roswell Park Cancer Institute | 2007-05-01 |
| Mediastinal Microdialysis in Patients With Oesophageal or Cardia Cancer Treated by Resection (NCT00686569) | Odense University Hospital | 2007-04-01 |
| Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus (NCT00474903) | National Cancer Institute (NCI) | 2007-04-01 |
| Esophageal Cancer in Northeastern Iran (NCT00450788) | National Cancer Institute (NCI) | 2007-03-15 |
| Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy (NCT01170845) | Yokohama City University Medical Center | 2007-03-01 |
| Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers (NCT01445327) | National Cancer Institute (NCI) | 2007-02-20 |
| Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia (NCT00665197) | International Atomic Energy Agency | 2007-02-01 |
| Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer (NCT00393068) | SCRI Development Innovations, LLC | 2007-02-01 |
| A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin (NCT01444547) | Chinese Academy of Medical Sciences | 2007-01-01 |
| Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery (NCT00445861) | Swiss Cancer Institute | 2007-01-01 |
| Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients (NCT00585117) | University of Wisconsin, Madison | 2006-12-01 |
| Pilot Study of 18F-FLT PET (NCT00585741) | University of Wisconsin, Madison | 2006-12-01 |
| Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer (NCT00372450) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-12-01 |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer (NCT00753844) | Kinki University | 2006-11-01 |
| PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer (NCT00669292) | Wakayama Medical University | 2006-11-01 |
| Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer (NCT00537121) | Roswell Park Cancer Institute | 2006-11-01 |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer (NCT00470184) | Roswell Park Cancer Institute | 2006-11-01 |
| Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer (NCT01254591) | University College London (UCL) Cancer Institute | 2006-11-01 |
| Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin (NCT00397904) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer (NCT00400114) | University Health Network, Toronto | 2006-09-25 |
| Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer (NCT00381706) | Alliance for Clinical Trials in Oncology | 2006-09-15 |
| Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer (NCT00394433) | Dana-Farber Cancer Institute | 2006-09-01 |
| Peptide Vaccination in Treating Patients With Esophageal Cancer (NCT00682227) | University of Yamanashi | 2006-08-01 |
| Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer (NCT00425425) | Technical University of Munich | 2006-07-01 |
| Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery (NCT00505024) | M.D. Anderson Cancer Center | 2006-07-01 |
| Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer (NCT00368329) | Stanford University | 2006-06-01 |
| Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer (NCT00344552) | Bristol-Myers Squibb | 2006-06-01 |
| Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer (NCT00453323) | National Cancer Center, Korea | 2006-06-01 |
| The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer (NCT00619242) | University of Chicago | 2006-06-01 |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer (NCT00711412) | Northwestern University | 2006-05-31 |
| INEC Study: Immuno-modulating Enteral Nutrition in Cancer (NCT00333099) | University Hospital, Clermont-Ferrand | 2006-05-01 |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer (NCT00354679) | Memorial Sloan Kettering Cancer Center | 2006-04-01 |
| Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery (NCT00268437) | Alliance for Clinical Trials in Oncology | 2006-04-01 |
| Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas (NCT00319735) | Nasser Hanna, M.D. | 2006-04-01 |
| Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer (NCT00524121) | Roswell Park Cancer Institute | 2006-03-01 |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors (NCT00335491) | University of Utah | 2006-03-01 |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer (NCT00387348) | Massachusetts General Hospital | 2006-03-01 |
| Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery (NCT00316862) | Alliance for Clinical Trials in Oncology | 2006-02-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Detection of Anastomotic Leakage After Esophageal Surgery (NCT00642525) | Heidelberg University | 2006-01-01 |
| Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma (NCT06476067) | City of Hope Medical Center | 2006-01-01 |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer (NCT00628368) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-11-01 |
| Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery (NCT00290719) | University of California, San Francisco | 2005-11-01 |
| Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer (NCT00258323) | Case Comprehensive Cancer Center | 2005-10-01 |
| Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates (NCT00130936) | AHS Cancer Control Alberta | 2005-10-01 |
| Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers (NCT00650988) | Case Comprehensive Cancer Center | 2005-09-01 |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer (NCT00215644) | Merck KGaA, Darmstadt, Germany | 2005-08-31 |
| Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction (NCT00107341) | Alliance for Clinical Trials in Oncology | 2005-08-01 |
| Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer (NCT00130689) | Dana-Farber Cancer Institute | 2005-07-01 |
| Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer (NCT00100945) | Alliance for Clinical Trials in Oncology | 2005-07-01 |
| Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers (NCT00291473) | Ludwig Institute for Cancer Research | 2005-07-01 |
| Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery (NCT00790140) | University of Dublin, Trinity College | 2005-07-01 |
| Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma (NCT00256269) | University of California, Irvine | 2005-06-01 |
| S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer (NCT00109850) | SWOG Cancer Research Network | 2005-05-01 |
| Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery (NCT00493025) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-04-01 |
| Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma (NCT00525915) | M.D. Anderson Cancer Center | 2005-04-01 |
| A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia (NCT00357682) | University of Oxford | 2005-03-10 |
| Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer (NCT00520091) | UNC Lineberger Comprehensive Cancer Center | 2005-03-01 |
| CCRT for Esophageal Cancer. (NCT02607982) | Hangzhou Cancer Hospital | 2005-01-01 |
| Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer (NCT00183898) | University of Southern California | 2004-12-28 |
| Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer (NCT00101907) | Amgen | 2004-12-01 |